PEDIATRICS Vol. 95 No. 6 June 1995, pp. 956-957
This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Eidelman, A. I.
Right arrow Articles by Schimmel, M. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Eidelman, A. I.
Right arrow Articles by Schimmel, M. S.

Drugs and Breast Milk

Arthur I. Eidelman MD1 and Michael S. Schimmel MD1

1 Department of Neonatology, Shaare Zedek Medical Center, Hebrew University-Hadassah Medical School, Jerusalem, Israel 91031

The recent publication of the Committee on Drugs of the American Academy of Pediatrics1 of an updated list of drugs and their potential effect on the infant or lactation is most welcome, given the increase both in the practice of breast-feeding and the awareness of the medical and lay public as to the adverse effect of drugs ingested by the nursing mother. In particular, the availability of newer antihypertensive and psychoactive agents for the treatment of common postpartum conditions inevitably leads to therapeutic dilemmas for the perinatal team concerned about the maternal-infant dyad.